Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Shanghai Changzheng Hospital
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Advanced Colorectal Cancer diagnosed histologically;
Patients with microsatellite stable (MSS)
Patients have no any standard choice after multiple line of therapy( ≥ 2 lines);
Expected survival ≥ 3 month;
ECOG / PS score: 0-2, and the main organ function to meet the following criteria: HB ≥ 90g / L, ANC ≥ 1.5 × 109 / L, PLT ≥ 80 × 109 / L,BIL \<1.5 times the upper limit of normal (ULN); Liver ALT and AST \<2.5 × ULN and if liver metastases, ALT and AST \<5 × ULN; Serum Cr ≤ 1 × ULN, endogenous creatinine clearance ≥50ml/min
You may not be if
Patient still has standard treatment therapy based on NCCN guidance;
Patient can not comply with research program requirements or follow-up;
Clareo Health | Regorafenib Plus PD-1 Inhibitor in Patients With Colorectal Cancer
